Jazz Pharmaceuticals plc Unrecognized Tax Benefits, Increase Resulting from Acquisition
Jazz Pharmaceuticals plc (JAZZ) reported Unrecognized Tax Benefits, Increase Resulting from Acquisition of $18.66 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition · last filed 2026-02-24
- Jazz Pharmaceuticals plc unrecognized tax benefits, increase resulting from acquisition for fiscal 2025 was $18.66M.
- Jazz Pharmaceuticals plc unrecognized tax benefits, increase resulting from acquisition for fiscal 2024 was $0.00.
- Jazz Pharmaceuticals plc unrecognized tax benefits, increase resulting from acquisition for fiscal 2023 was $0.00.
- Jazz Pharmaceuticals plc unrecognized tax benefits, increase resulting from acquisition for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Acquisition 12 month |
|---|---|
| 2025-12-31 | $18.66M 10-K · filed 2026-02-24 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-24 |
| 2023-12-31 | $0.00 10-K · filed 2026-02-24 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-28 |
| 2021-12-31 | $5.92M 10-K · filed 2024-02-28 |
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 |
| 2019-12-31 | $0.00 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |